They improve blood glucose control by stimulating insulin secretion, reducing glucagon release, slowing gastric emptying, and increasing feelings of fullness
This unique mechanism makes it a promising option for metabolic health support
The study looked back on their health records for up to three years, beginning when they started taking either a GLP-1 receptor agonist most commonly semaglutide, liraglutide or dulaglutide or another type of medication, called an SGLT2 inhibitor, to treat their diabetes
There are risks, benefits and possible side effects to medications and, if discussed, they can help you navigate through the possible effects. Finally, Orandi offered strategies to help minimize side effects that people should follow when taking GLP-1 medications in general
If cardiovascular health is what you think is important for deciding between these drug classes, I think our most recent study provides some strong evidence
I finally summoned up enough willpower to force myself to get this done on day 3 (Im sorry Cate Hall, I know you disagree with this definition)